L 636028

We are open as normal during COVID-19 pandemic. Order online, same day shipping out.

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 596571

CAS#: 104199-89-5

Description: L 636028 is a bioactive chemical.


Price and Availability

Size Price Shipping out time Quantity
Inquire bulk and customized quantity

Pricing updated 2020-03-30. Prices are subject to change without notice.

L 636028 is not in stock, may be available through custom synthesis. For cost-effective reason, minimum 1 gram order is requested. The product will be characterized by NMR, HPLC and MS analysis. Purity (HPLC) is usually >98%. CoA, QC data, MSDS will be provided when product is successfully made. The estimated lead time is 2-3 months. Please send email to sales@medkoo.com to inquire quote.


Chemical Structure

img

Theoretical Analysis

MedKoo Cat#: 596571
Name: L 636028
CAS#: 104199-89-5
Chemical Formula: C22H36N2O2
Exact Mass: 360.2777
Molecular Weight: 360.54
Elemental Analysis: C, 73.29; H, 10.06; N, 7.77; O, 8.87


Synonym: L 636028; L-636028; L636028;

IUPAC/Chemical Name: N,N-diethyl-1-methyl-2-oxohexadecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide

InChi Key: RXOXVGQPEWPTHM-UHFFFAOYSA-N

InChi Code: InChI=1S/C22H36N2O2/c1-4-24(5-2)22(26)19-9-8-14-15-10-12-20-18(11-13-21(25)23(20)3)16(15)6-7-17(14)19/h14-20H,4-13H2,1-3H3

SMILES Code: O=C(C1CCC2C1CCC3C4CCC(N(C)C4CCC32)=O)N(CC)CC


Technical Data

Appearance:
Solid powder

Purity:
>98% (or refer to the Certificate of Analysis)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility:
Soluble in DMSO

Shelf Life:
>2 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code:
2934.99.9001


References

1: Labrie C, Trudel C, Li S, Martel C, Couêt J, Labrie F. Combination of an antiandrogen and a 5 alpha-reductase inhibitor: a further step towards total androgen blockade? Endocrinology. 1991 Jul;129(1):566-8. PubMed PMID: 2055205.

2: Greger NG, Insull W Jr, Probstfield JL, Keenan BS. High-density lipoprotein response to 5-alpha-dihydrotestosterone and testosterone in Macaca fascicularis: a hormone-responsive primate model for the study of atherosclerosis. Metabolism. 1990 Sep;39(9):919-24. PubMed PMID: 2392061.

3: Connolly PB, Resko JA. Role of steroid 5 alpha-reductase activity in sexual differentiation of the guinea pig. Neuroendocrinology. 1989 Mar;49(3):324-30. PubMed PMID: 2716956.

4: Sonderfan AJ, Parkinson A. Inhibition of steroid 5 alpha-reductase and its effects on testosterone hydroxylation by rat liver microsomal cytochrome P-450. Arch Biochem Biophys. 1988 Aug 15;265(1):208-18. PubMed PMID: 3415243.

5: Leray G, Shacoori V, Prodhomme C, Jouanolle AM, Blayau M. Alpha-L-fucosidase in rat testis during sexual maturity. Arch Androl. 1988;21(1):23-8. PubMed PMID: 3190358.

6: Alexandre C, Balthazart J. Inhibition of testosterone metabolism in the brain and cloacal gland of the quail by specific inhibitors and antihormones. J Endocrinol. 1987 Feb;112(2):189-95. PubMed PMID: 2950196.